Hans Keirstead | Chairman
Immunis Inc.

Hans Keirstead, Chairman, Immunis Inc.

Dr. Keirstead is an internationally renowned stem cell expert who has pioneered therapies for cancer, immune disorders, motor neuron diseases, spinal cord injury and retinal diseases. For over two decades, Dr. Keirstead has lead investigations on regenerative medicine. He spent 15-years as a full-tenured Professor of Anatomy and Neurobiology at UC Irvine, mentoring 100+ students, publishing 100+ manuscripts and receiving over 20 patents. He is currently the CEO of AIVITA Biomedical and the Chairman of his newly developed company Immunis, Inc., which investigates the stem cell secretome as an immunomodulator for age-related disease.


Festival of Biologics Day 2 @ 16:40

A Secretome Clinical Trial Targeting Age-Acquired Immune Deficiency

last published: 26/Jan/23 10:35 GMT
last published: 26/Jan/23 10:35 GMT

back to speakers